Evidence map›Paper›PMID 38955979›Full record

ArticleNetherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation2024

Impact of symptom duration and mechanical circulatory support on prognosis in cardiogenic shock complicating acute myocardial infarction.

Florien Klein, Caïa Crooijmans, Elma J Peters, Marcel van 't Veer, Marijke J C Timmermans, José P S Henriques, Niels J W Verouden, Adriaan O Kraaijeveld, Jeroen J H Bunge, Erik Lipsic and 13 more

Abstract read
In one paragraph

Article in Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Advancing cardiovascular care-key insights from the Netherlands Heart Journal 2024.Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation · 2024
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors.

Florien KleinHeart Centre, Department of Interventional Cardiology, Catharina Hospital Eindhoven, Eindhoven, The Netherlands. florien.klein@catharinaziekenhuis.nl.
Caïa CrooijmansHeart Centre, Department of Interventional Cardiology, Catharina Hospital Eindhoven, Eindhoven, The Netherlands.
Elma J PetersHeart Centre, Department of Cardiology, Amsterdam University Medical Centres, Amsterdam, The Netherlands.
Marcel van 't VeerHeart Centre, Department of Interventional Cardiology, Catharina Hospital Eindhoven, Eindhoven, The Netherlands.
Marijke J C TimmermansNetherlands Heart Registration, Utrecht, The Netherlands.
José P S HenriquesHeart Centre, Department of Cardiology, Amsterdam University Medical Centres, Amsterdam, The Netherlands.
Niels J W VeroudenHeart Centre, Department of Cardiology, Amsterdam University Medical Centres, Amsterdam, The Netherlands.
Adriaan O KraaijeveldDepartment of Cardiology, Utrecht University Medical Centre, Utrecht, The Netherlands.
Jeroen J H BungeDepartment of Cardiology, Erasmus University Medical Centre, Rotterdam, The Netherlands.
Erik LipsicDepartment of Cardiology, University Medical Centre Groningen, Groningen, The Netherlands.
Krischan D SjauwDepartment of Cardiology, St. Antonius Hospital, Nieuwegein, The Netherlands.
Robert-Jan M van GeunsDepartment of Cardiology, Radboud University Medical Centre, Nijmegen, The Netherlands.
Admir DedicDepartment of Cardiology, Noordwest Clinics, Alkmaar, The Netherlands.
Eric A DuboisDepartment of Cardiology, Erasmus University Medical Centre, Rotterdam, The Netherlands.
Martijn MeuwissenDepartment of Cardiology, Amphia Hospital, Breda, The Netherlands.
Peter DanseDepartment of Cardiology, Rijnstate Hospital, Arnhem, The Netherlands.
Gabe BleekerDepartment of Cardiology, Haga Hospital, The Hague, The Netherlands.
José M Montero-CabezasDepartment of Cardiology, Leiden University Medical Centre, Leiden, The Netherlands.
Irlando A FerreiraDepartment of Cardiology, Isala Hospital, Zwolle, The Netherlands.
Jan BrouwerDepartment of Cardiology, Medical Centre Leeuwarden, Leeuwarden, The Netherlands.
Koen TeeuwenHeart Centre, Department of Interventional Cardiology, Catharina Hospital Eindhoven, Eindhoven, The Netherlands.
Luuk C OtterspoorHeart Centre, Department of Interventional Cardiology, Catharina Hospital Eindhoven, Eindhoven, The Netherlands.
PCI registration committee of the Netherlands Heart Registration

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMortality rates in patients with cardiogenic shock complicating acute myocardial infarction (AMICS) remain high despite advancements in AMI care. Our study aimed to investigate the impact of prehospital symptom duration on the prognosis of AMICS patients and those receiving mechanical circulatory support (MCS). METHODS AND

resultsWe conducted a retrospective cohort study with data registered in the Netherlands Heart Registration. A total of 1,363 patients with AMICS who underwent percutaneous coronary intervention between 2017 and 2021 were included. Patients presenting after out-of-hospital cardiac arrest were excluded. Most patients were male (68%), with a median age of 69 years (IQR 61-77), predominantly presenting with ST-elevation myocardial infarction (86%). The overall 30-day mortality was 32%. Longer prehospital symptom duration was associated with a higher 30-day mortality with the following rates: < 3 h, 26%; 3-6 h, 29%; 6-24 h, 36%; ≥ 24 h, 46%; p < 0.001. In a subpopulation of AMICS patients with MCS (n = 332, 24%), symptom duration of > 24 h was associated with significantly higher mortality compared to symptom duration of < 24 h (59% vs 45%, p = 0.029). Multivariate analysis identified > 24 h symptom duration, age and in-hospital cardiac arrest as predictors of 30-day mortality in MCS patients.

conclusionProlonged prehospital symptom duration was associated with significantly increased 30-day mortality in patients presenting with AMICS. In AMICS patients treated with MCS, a symptom duration of > 24 h was an independent predictor of poor survival. These results emphasise the critical role of early recognition and intervention in the prognosis of AMICS patients.

Indexed as

Acute myocardial infarctionCardiogenic shockMortalitySymptom duration

Identifiers

PMID38955979
PMCPMC11239615

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.